In the latest development of a years-long legal saga, Eli Lilly is going to trial.
District Court Judge Harry Leinenweber signed an order denying Eli Lilly’s motion to dismiss a court case from whistleblower Ronald Streck on behalf of the federal government.
The case, originally filed in the US District Court for Northern Illinois, will now go before a jury, which will have to decide whether Lilly’s actions were intentional and if the Big Pharma caused the government and certain state Medicaid agencies to lose money.
Unlock this story instantly and join 135,900+ biopharma pros reading Endpoints daily — and it's free.
When MorphoSys swooped in with a $1.7 billion deal to buy Constellation Pharmaceuticals last year, then CEO Jigar Raythatha paid tribute to the nearly 200 staffers who had been working on everything from discovery through late-stage work. Today, though, the German company said the only thing it wants to keep in the deal is in the clinic, and it’s exporting that work to Europe after shuttering everything else.
Unlock this story instantly and join 135,900+ biopharma pros reading Endpoints daily — and it's free.
Changing the world with a disruptive new vaccine...
NC said Thursday it has filed a criminal complaint against the operator of the YouTube channel "Yeonglaegi" on charges of spreading false information and obstructing business operations related to...